A 17-year-old female presented with high fever, general fatigue, and dim eyesight. She had used colored contact lenses 3 weeks previously. Traumatic injury of the eye vessels led to systemic hematogenous infection and subsequent endocarditis.
Assessing heart failure progression in patients with Duchenne muscular dystrophy is challenging due to the multisystem nature of the disease. This is the first use of an implantable pulmonary artery pressure monitor.
Diagnosing pediatric hypertension is difficult, and adherence to treatment guidelines is poor. What approaches and interventions can help treat these patients and reduce ensuing cardiovascular events in adulthood?
Genetic screening for risk of sudden cardiac death in a 15-year-old boy with relevant family history uncovered a high chance of arrhythmogenic right ventricular cardiomyopathy. An ICD was implanted, and shortly after it successfully treated a potentially fatal ventricular arrhythmia.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.
A 17-year-old female presented with high fever, general fatigue, and dim eyesight. She had used colored contact lenses 3 weeks previously. Traumatic injury of the eye vessels led to systemic hematogenous infection and subsequent endocarditis.
Assessing heart failure progression in patients with Duchenne muscular dystrophy is challenging due to the multisystem nature of the disease. This is the first use of an implantable pulmonary artery pressure monitor.
Genetic screening for risk of sudden cardiac death in a 15-year-old boy with relevant family history uncovered a high chance of arrhythmogenic right ventricular cardiomyopathy. An ICD was implanted, and shortly after it successfully treated a potentially fatal ventricular arrhythmia.
An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.
